CXCR2 and amyotrophic lateral sclerosis: Based on these promising results, we believe that drugs attenuating CXCR2-mediated neurotoxicity may confer neuroprotection against the inflammatory cascade and oxidative damage in ALS pathogenesis (Fig. 5).